PHAT

PHAT Net Income Growth

69.99%TTM

Period ending:

PHAT TTM Net Income YoY %%
PHAT TTM Net Income YoY %2443.39%-22081.70%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

PHAT net income growth history

Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Phathom Pharmaceuticals Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
69.9922%
54.51%
33.823%
19.1177%
-11.1218%
-40.2065%
-65.8437%
-91.7015%
-60.6721%
-26.5595%
-1.9563%
0.8028%
-12.7041%
-30.1707%
-37.4193%
-10.3376%
-3.0473%
-4.1281%
-11.4784%
6.6771%
23.2152%
47.5332%
49.4111%
-9.9893%
-130.9466%
-11,907.9316%
-19,708.3075%

Compare net income growth

Other companies in Health Care. Each page shows its own reporting periods and currency.

Compare all covered stocks by net income growth →

All PHAT financial metrics · PHAT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.